Skip to main content
. 2018 Sep 27;33(6):304–311. doi: 10.1097/YIC.0000000000000236

Fig. 1.

Fig. 1

Patient disposition. One patient was erroneously randomized to vilazodone 40 mg/day and therefore not included in any double-blind safety or ITT analysis. DB, double-blind; ITT, intent-to-treat; OL, open-label.